Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Net Margin (2020 - 2022)

Historic Net Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 2134.2%.

  • Therapeutics' Net Margin fell 2803400.0% to 2134.2% in Q2 2022 from the same period last year, while for Mar 2023 it was 10900.68%, marking a year-over-year decrease of 86275600.0%. This contributed to the annual value of 5618.53% for FY2022, which is 38035800.0% down from last year.
  • As of Q2 2022, Therapeutics' Net Margin stood at 2134.2%, which was down 2803400.0% from 3241.34% recorded in Q1 2022.
  • Therapeutics' Net Margin's 5-year high stood at 957.53% during Q3 2020, with a 5-year trough of 3241.34% in Q1 2022.
  • Over the past 3 years, Therapeutics' median Net Margin value was 1629.55% (recorded in 2021), while the average stood at 1719.4%.
  • Per our database at Business Quant, Therapeutics' Net Margin surged by 538500bps in 2021 and then crashed by -18899500bps in 2022.
  • Therapeutics' Net Margin (Quarter) stood at 978.11% in 2020, then plummeted by -142bps to 2371.56% in 2021, then rose by 10bps to 2134.2% in 2022.
  • Its Net Margin stands at 2134.2% for Q2 2022, versus 3241.34% for Q1 2022 and 2371.56% for Q4 2021.